Resilient Together for Dementia (RT-D)
This study will evaluate the feasibility and preliminary efficacy of the novel Resilient
Together for Dementia (RT-D) intervention for couples following dementia diagnoses. The
primary target is emotional distress, and the program aims to prevent chronic distress in
...
Age: 18 years - 66+
Gender: All
Resilient Together for Dementia
The proposed study will establish the feasibility, acceptability and credibility of a novel
live video dyadic resiliency intervention, Resilient Together for Dementia (RT-D), aimed at
preventing chronic emotional distress and preserving quality of life among dyads a...
Age: 65 years - 66+
Gender: All
Palliative Care for Patients with Dementia
A multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the
effectiveness of a novel model of in-home palliative care for dementia patients and their
family caregivers. From inpatient and outpatient settings associated with four hospitals
acro...
Age: 65 years - 66+
Gender: All
Palliative Care for Patients With Dementia
A multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the
effectiveness of a novel model of in-home palliative care for dementia patients and their
family caregivers. From inpatient and outpatient settings associated with four hospitals
acro...
Age: 65 years - 66+
Gender: All
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
The overall goal of the DISCOVERY study is to better understand what factors contribute
to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced
a stroke. The purpose of the study is to help doctors identify patients at risk for
demen...
Age: 18 years - 66+
Gender: All
An Efficacy and Safety Study of JNJ-54861911 in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
The purpose of this study is to evaluate whether treatment with JNJ-54861911 slows cognitive
decline compared with placebo treatment, as measured by a composite cognitive measure, the
Preclinical Alzheimer Cognitive Composite (PACC), in amyloid-positive participants w...
Age: 60 - 85 years
Gender: All